CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to JNJ

Rabeprazole sodium 5 mg

Phase 3
Johnson & Johnson (JNJ)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in Gastroesophageal Reflux

View Full Landscape
Drug Information

Target Indication

Gastroesophageal Reflux

Clinical Trial

NCT00992589

Last updated: 12/4/2025

Patent & Exclusivity
No Patent DataRLD

Application

NDA 020973
Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.